Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 11;17(1):e3000105.
doi: 10.1371/journal.pbio.3000105. eCollection 2019 Jan.

Resolving the apparent transmission paradox of African sleeping sickness

Affiliations

Resolving the apparent transmission paradox of African sleeping sickness

Paul Capewell et al. PLoS Biol. .

Abstract

Human African trypanosomiasis (HAT), or African sleeping sickness, is a fatal disease found throughout sub-Saharan Africa. The disease is close to elimination in many areas, although it was similarly close to elimination once before and subsequently reemerged, despite seemingly low rates of transmission. Determining how these foci persisted and overcame an apparent transmission paradox is key to finally eliminating HAT. By assessing clinical, laboratory, and mathematical data, we propose that asymptomatic infections contribute to transmission through the presence of an overlooked reservoir of skin-dwelling parasites. Our assessment suggests that a combination of asymptomatic and parasitaemic cases is sufficient to maintain transmission at foci without animal reservoirs, and we argue that the current policy not to treat asymptomatic HAT should be reconsidered.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Modelling of the relative contributions of asymptomatic and clinical cases to R0 in a polymorphic human HAT focus without animal reservoirs.
We estimated the contribution of asymptomatic and clinical infections to R0 (the basic reproductive number) under equilibrium prevalence by adapting a previously published trypanosomiasis transmission model [11]. Consistent with empirical data showing no domestic or wildlife reservoir, we removed the nonhuman-animal contribution to R0 and instead allowed for a polymorphic human population in which a fraction (f) of the population develop clinical infections when infected (population I), with the remainder (1–f) developing asymptomatic infections (population II). This leads to R0=1(1iv*)(II*+III*)[II*1II*fN+III*1III*(1f)N], where i*v is the infected tsetse prevalence, II* is the number of clinical infections present at equilibrium, III* is the number of asymptomatic infections at equilibrium, and N is the total human population size. We simulated this equation with epidemiologic and demographic surveys from the Forécariah focus in Guinea. Specifically, there were 13 clinical infections and 16 suspected asymptomatic infections identified during the survey. Of the suspected asymptomatic individuals, one-third tested negative on follow-up using the TL test and one-third developed symptoms [10]. Therefore, we set the number of asymptomatic infections as III* = 16X (where X~Uniform(1/3,1)) and the number of clinical infections as II* = 29–III*. The total population size was set as N = 10,837, based on 7,586 surveyed individuals and a survey completeness of 70%. These results suggest that transmission is not sustainable (R0 < 1) when nearly all infections are either clinical (f > 0.98) or asymptomatic infections (f < 0.02). The shaded areas represent 95% predictive intervals when the number of asymptomatic and clinical infections were sampled 1,000 times. HAT, human African trypanosomiasis; TL, trypanolysis.

References

    1. WHO. Control and surveillance of human African trypanosomiasis: report of a WHO Expert Committee [on Control and Surveillance of Human African Trypanosomiasis, Geneva, 22–26 April 2013]. Geneva: World Health Organization; 2013.
    1. Franco JR, Cecchi G, Priotto G, Paone M, Diarra A, Grout L, et al. Monitoring the elimination of human African trypanosomiasis: Update to 2014. Boelaert M, editor. PLoS Negl Trop Dis. 2017;11: e0005585 10.1371/journal.pntd.0005585 - DOI - PMC - PubMed
    1. Kagbadouno MS, Camara M, Rouamba J, Rayaisse J-B, Traoré IS, Camara O, et al. Epidemiology of Sleeping Sickness in Boffa (Guinea): Where Are the Trypanosomes? Matovu E, editor. PLoS Negl Trop Dis. 2012;6: e1949 10.1371/journal.pntd.0001949 - DOI - PMC - PubMed
    1. Koffi M, Solano P, Denizot M, Courtin D, Garcia A, Lejon V, et al. Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: A potential human reservoir of parasites? Acta Trop. 2006;98: 183–188. 10.1016/j.actatropica.2006.04.001 - DOI - PubMed
    1. Büscher P, Bart J-M, Boelaert M, Bucheton B, Cecchi G, Chitnis N, et al. Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination? Trends Parasitol. 2018;34: 197–207. 10.1016/j.pt.2017.11.008 - DOI - PMC - PubMed

MeSH terms